🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- M4130Y106 (prev. M20156101 )
- Market Cap
- Small Cap
- IPO
- 7/30/2014 · $11.00/share
- Previous Symbol
- ORPN (changed 3/25/2019)
- Previous Name
- Bio Blast Pharma Ltd.
Business: Enlivex Therapeutics Ltd. is developing a novel immunotherapy candidate with a unique mode of action that targets clinical indications defined as life-threatening, unmet medical need,” such as preventing or treating complications associated with bone-marrow transplantations, sepsis – which is the third-leading cause of mortality in the United States after cardiovascular and cancer diseases, as well as treatment of solid tumors via immune checkpoint reprogramming, potentially increasing the efficacy of CAR-T, TCR and other anti-cancer therapies.
Company Contact
- CEO
- Oren Hershkovitz
- CFO
- Shachar Shlosberger
- Investor Relations
- Dave Gentry, RedChip Companies, Inc. · 407-644-4256 · ENLV@redchip.com